|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/135 |
| (11) | Number of the document | 2381767 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10733731.3 |
| Date of filing the European patent application | 2010-01-21 | |
| (97) | Date of publication of the European application | 2011-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/000174 |
| Date | 2010-01-21 |
| (87) | Number | WO 2010/085354 |
| Date | 2010-07-29 |
| (30) | Number | Date | Country code |
| 689044 | 2010-01-18 | US | |
| 456029 | 2009-06-09 | US | |
| 456001 | 2009-06-09 | US | |
| 456031 | 2009-06-09 | US | |
| 205833 P | 2009-01-23 | US | |
| 455976 | 2009-06-09 | US |
| (72) |
SAFADI, Muhammad, IL
LICHT, Daniella, IL
COHEN, Rachel, IL
FRENKEL, Anton, IL
KOLTAI, Tamas, IL
ZHOLKOVSKY, Marina, IL
|
| (73) |
Teva Pharmaceutical Industries Ltd.,
5 Basel Street P.O. Box 3190, 49131 Petah Tiqva,
IL
|
| (54) | DELAYED RELEASE RASAGILINE FORMULATION |
| DELAYED RELEASE RASAGILINE FORMULATION |